Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, resulting in central nervous system depression.
## Primary Indications
* Management of anxiety disorders
* Short-term relief of insomnia
* Preanesthetic medication to induce sedation and reduce anxiety
* Management of status epilepticus and seizure disorders
## Adult Dosing
* **Anxiety:** 1-3 mg orally every 8-12 hours. Maximum daily dose typically 10 mg.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Preanesthetic:** 2-4 mg intramuscularly or intravenously 2 hours before surgery.
* **Status Epilepticus:** 4 mg intravenously administered slowly (not exceeding 2 mg/min). May repeat in 5-10 minutes if seizure persists. Maximum initial dose 8 mg. Further doses should be guided by clinical response.
Dosing for specific indications and patient populations may vary based on institutional protocols and clinical judgment.
## Pediatric Dosing
Dosing in pediatric patients is less established and requires careful consideration of weight, age, and clinical condition.
* **Anxiety:** There is no universally accepted pediatric dose. Dosing often starts at 0.02-0.05 mg/kg/dose orally every 6-8 hours.
* **Seizures (Status Epilepticus):** 0.1 mg/kg intravenously, not to exceed 4 mg. May be repeated once after 5-10 minutes if seizure persists.
**Caution:** Use in children under 12 years for anxiety or insomnia is generally not recommended due to lack of established safety and efficacy.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment is usually recommended unless severe impairment.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, fatigue, ataxia, weakness, confusion.
Less common: Hypotension, amnesia, paradoxical reactions (e.g., excitation, aggression), respiratory depression (especially with IV administration or in combination with other CNS depressants).
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, sedatives, antihistamines):** Additive CNS depression, increased risk of respiratory depression and sedation.
* **CYP450 Inhibitors/Inducers:** While lorazepam is not extensively metabolized by CYP enzymes, interactions are possible with agents that affect its glucuronidation (e.g., probenecid may decrease clearance).
## Monitoring
* Sedation level
* Respiratory rate and depth
* Blood pressure and heart rate
* Cognitive function
* Signs of withdrawal upon discontinuation
## Clinical Pearls
* Lorazepam has a relatively long half-life, but its effects can be rapid, especially with IV administration.
* IV lorazepam should be administered slowly to avoid hypotension and respiratory depression.
* Abrupt discontinuation can lead to withdrawal symptoms, including insomnia, anxiety, tremors, and seizures. Tapering is recommended for prolonged use.
* Tolerance can develop with chronic use, requiring dose escalation.
* Consider the potential for abuse and dependence.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant literature for complete details and to verify dosing and safety before administering any medication.*
